Results: 1-25 | 26-35
Results: 1-25/35

Authors: Jones, D Dang, NH Duvic, M Washington, LT Huh, YO
Citation: D. Jones et al., Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood, AM J CLIN P, 115(6), 2001, pp. 885-892

Authors: Lu, D Duvic, M Medeiros, LJ Luthra, R Dorfman, DM Jones, D
Citation: D. Lu et al., The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides, AM J CLIN P, 115(3), 2001, pp. 413-421

Authors: Ni, X Hazarika, P Zhang, CL Tapur, R Duvic, M
Citation: X. Ni et al., Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+cytotoxic T lymphocytes in mycosis fungoides: A potential mechanism of tumor immune escape?, CLIN CANC R, 7(9), 2001, pp. 2682-2692

Authors: Duvic, M Nelson, A de Andrade, M
Citation: M. Duvic et al., The genetics of alopecia areata, CLIN DERMAT, 19(2), 2001, pp. 135-139

Authors: Apisarnthanarax, N Duvic, M
Citation: N. Apisarnthanarax et M. Duvic, Cutaneous T-cell lymphoma - New immunomodulators, DERM CLIN, 19(4), 2001, pp. 737

Authors: Werth, VP Duvic, M
Citation: Vp. Werth et M. Duvic, Medical dermatology - Preface, DERM CLIN, 19(4), 2001, pp. XI-XI

Authors: Duvic, M Hymes, K Heald, P Breneman, D Martin, AG Myskowski, P Crowley, C Yocum, RC
Citation: M. Duvic et al., Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: Multinational phase II-III trial results, J CL ONCOL, 19(9), 2001, pp. 2456-2471

Authors: Olsen, E Duvic, M Frankel, A Kim, Y Martin, A Vonderheid, E Jegasothy, B Wood, G Gordon, M Heald, P Oseroff, A Pinter-Brown, L Bowen, G Kuzel, T Fivenson, D Foss, F Glode, M Molina, A Knobler, E Stewart, S Cooper, K Stevens, S Craig, F Reuben, J Bacha, P Nichols, J
Citation: E. Olsen et al., Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma, J CL ONCOL, 19(2), 2001, pp. 376-388

Authors: Sarris, AH Braunschweig, I Medeiros, LJ Duvic, M Ha, CS Rodriguez, MA Hagemeister, FB McLaughlin, P Romaguera, J Cox, J Cabanillas, F
Citation: Ah. Sarris et al., Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: Preferential cutaneous relapses but high cure rate with doxorubicin-based therapy, J CL ONCOL, 19(2), 2001, pp. 398-405

Authors: McMullan, DM Radovancevic, B Jackow, CM Frazier, OH Duvic, M
Citation: Dm. Mcmullan et al., Cutaneous T-cell lymphoma in a cardiac transplant recipient, TEX HEART I, 28(3), 2001, pp. 203-207

Authors: Sober, AJ Chuang, TY Duvic, M Farmer, ER Grichnik, JM Halpern, AC Ho, V Holloway, V Hood, AF Johnson, TM Lowery, BJ
Citation: Aj. Sober et al., Guidelines of care for primary cutaneous melanoma, J AM ACAD D, 45(4), 2001, pp. 579-586

Authors: Hwong, H Nichols, T Duvic, M
Citation: H. Hwong et al., "Invisible" mycosis fungoides?, J AM ACAD D, 45(2), 2001, pp. 318-318

Authors: Duvic, M Olsen, EA Omura, GA Maize, JC Vonderheid, EC Elmets, CA Shupack, JL Demierre, MF Kuzel, TM Sanders, DY
Citation: M. Duvic et al., A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma, J AM ACAD D, 44(6), 2001, pp. 940-947

Authors: McMillen, R Duvic, M
Citation: R. Mcmillen et M. Duvic, Alopecia areata occurring in sisters after administration of rifampicin, J AM ACAD D, 44(1), 2001, pp. 142-143

Authors: Pielop, JA Jones, D Duvic, M
Citation: Ja. Pielop et al., Transient CD30+nodal transformation of cutaneous T-cell lymphoma associated with cyclosporine treatment, INT J DERM, 40(8), 2001, pp. 505-511

Authors: Feasel, AM Donato, ML Duvic, M
Citation: Am. Feasel et al., Complete remission of scleromyxedema following autologous stem cell transplantation, ARCH DERMAT, 137(8), 2001, pp. 1071-1072

Authors: Duvic, M Martin, AG Kim, Y Olsen, E Wood, GS Crowley, CA Yocum, RC
Citation: M. Duvic et al., Phase 2 and 3 clinical trial of oral bexarotene (targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma, ARCH DERMAT, 137(5), 2001, pp. 581-593

Authors: Duvic, M Helekar, B Schulz, C Cho, M DiSepio, D Hager, C DiMao, D Hazarika, P Jackson, B Breuer-McHam, J Young, J Clayman, G Lippman, SM Chandraratna, RAS Robinson, NA Deucher, A Eckert, RL Nagpal, S
Citation: M. Duvic et al., Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer, CLIN CANC R, 6(8), 2000, pp. 3249-3259

Authors: Breuer-McHam, JN Ledbetter, LS Sarris, AH Duvic, M
Citation: Jn. Breuer-mcham et al., Cytokine expression patterns distinguish HIV associated skin diseases, EXP DERMATO, 9(5), 2000, pp. 341-350

Authors: Duvic, M Cather, JC
Citation: M. Duvic et Jc. Cather, Emerging new therapies for cutaneous T-cell lymphoma, DERM CLIN, 18(1), 2000, pp. 147

Authors: Krueger, GG Feldman, SR Camisa, C Duvic, M Elder, JT Gottlieb, AB Koo, J Krueger, JG Lebwohl, M Lowe, N Menter, A Morison, WL Prystowsky, JH Shupack, JL Taylor, JR Weinstein, GD Barton, TL Rolstad, T Day, RM
Citation: Gg. Krueger et al., Two considerations for patients with psoriasis and their clinicians: What defines mild, moderate, and severe psoriasis? What constitutes a clinicallysignificant improvement when treating psoriasis?, J AM ACAD D, 43(2), 2000, pp. 281-285

Authors: Duvic, M Friedman-Kien, AE Looney, DJ Miles, SA Myskowski, PL Scadden, DT Von Roenn, J Galpin, JE Groopman, J Loewen, G Stevens, V Truglia, JA Yocum, RC
Citation: M. Duvic et al., Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel - Results of phase 1 and 2trials, ARCH DERMAT, 136(12), 2000, pp. 1461-1469

Authors: Price, VH Moshell, AN Stenn, KS Duvic, M Goldsmith, LA Cork, MJ Happle, R Kalabokes, V
Citation: Vh. Price et al., Third International Research Workshop on Alopecia Areata - Introduction, J INV D SYM, 4(3), 1999, pp. 199-199

Authors: de Andrade, M Jackow, CM Dahm, N Hordinsky, M Reveille, JD Duvic, M
Citation: M. De Andrade et al., Alopecia areata in families: Association with the HLA locus, J INV D SYM, 4(3), 1999, pp. 220-223

Authors: Lee, BN Duvic, M Tang, CK Bueso-Ramos, C Estrov, Z Reuben, JM
Citation: Bn. Lee et al., Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma, CL DIAG LAB, 6(1), 1999, pp. 79-84
Risultati: 1-25 | 26-35